Clinical Trial Details
EORTC-24971
Back to Clinical Trials Database
A randomized phase III multicenter trial of neoadjuvant docetaxel (Taxotere) plus cisplatin plus 5-fluorouracil versus neoadjuvant cisplatin plus 5-fluorouracil in patients with locally advanced inoperable squamous cell carcinoma of the head and neck
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 13-Apr-1999 Date Step1 close: 15-Mar-2002 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 348 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00003888 |
NCT number | NCT00003888 |